Furosemide Injection USP — Class II drug recall D-169-2013
Terminated recall by Hospira, Inc., reported 2013-03-06, distributed nationwide. Lack of Assurance of Sterility; possible loose crimp applied to fliptop vial
| Recall number | D-169-2013 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Hospira, Inc., Rocky Mount, NC, United States |
| Recall initiated | 2013-01-10 |
| Classified | 2013-02-26 |
| Reported by FDA | 2013-03-06 |
| Terminated | 2014-10-08 |
| Distributed | Nationwide (US) |
| Quantity | 63,900 vials |
| Reason classes | sterility |
| NDC | 00409-6102, 00409-6102-02, 00409-6102-04, 00409-6102-10, 00409-6102-18, 00409-6102-19, 00409-6102-20 |
Product
Furosemide Injection USP (10 mg/mL), 4 mL in 5 mL Fliptop Vial, Rx only, Hospira Inc., Lake Forest, IL --- NDC 0409-6102-04
Reason for recall
Lack of Assurance of Sterility; possible loose crimp applied to fliptop vial
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-169-2013. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.